Toward Point-of-Care Diagnostics to Monitor MMP-9 and TNF-α Levels in Inflammatory Bowel Disease
Authors:
Open Access
- 3 March 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 6 (10) , 6582-6587
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering (R21-EB025049)
This publication has 29 references indexed in Scilit:
- An aptamer-gated silica mesoporous material for thrombin detectionChemical Communications, 2013
- Multifunctional Up‐Converting Nanocomposites with Smart Polymer Brushes Gated Mesopores for Cell Imaging and Thermo/pH Dual‐Responsive Drug Controlled ReleaseAdvanced Functional Materials, 2013
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Antibody‐Capped Mesoporous Nanoscopic Materials: Design of a Probe for the Selective Chromo‐Fluorogenic Detection of FinasterideChemistryOpen, 2012
- Silica-based nanoparticles for biomedical applicationsDrug Discovery Today, 2012
- Enzyme‐Mediated Controlled Release Systems by Anchoring Peptide Sequences on Mesoporous Silica SupportsAngewandte Chemie International Edition, 2011
- Fluorescent pH-Sensing Organic/Inorganic Hybrid Mesoporous Silica Nanoparticles with Tunable Redox-Responsive Release CapabilityLangmuir, 2010
- Controlling the delivery kinetics from colloidal mesoporous silica nanoparticles with pH-sensitive gatesJournal of Materials Chemistry, 2010
- Controlled Delivery Systems Using Antibody-Capped Mesoporous NanocontainersJournal of the American Chemical Society, 2009
- Continuously recording fluorescent assays optimized for five human matrix metalloproteinasesAnalytical Biochemistry, 1991